Submitted by Anonymous (not verified) on 17 October 2025 - 11:00    
  
  Human medicines European public assessment report (EPAR): Rezurock, Belumosudil, Status: Opinion
Source: 
Human medicines European public assessment report (EPAR): Rezurock, Belumosudil, Status: Opinion